Clavudale 400 mg/100 mg tablets for dogs אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

clavudale 400 mg/100 mg tablets for dogs

dechra regulatory b.v. - amoxicillin trihydrate; potassium clavulanate - tablet - 400, 100 mg/tablet - amoxicillin and enzyme inhibitor

DOXYLIN 100 doxycycline 100mg (as hyclate) tablet blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

doxylin 100 doxycycline 100mg (as hyclate) tablet blister pack

alphapharm pty ltd - doxycycline hyclate, quantity: 115 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; quinoline yellow; macrogol 4000 - doxycycline is indicated in the treatment of infections caused by the following microorganisms: mycoplasma pneumoniae: primary atypical pneumonia; rickettsiae: queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus; chlamydia psittaci: psittacosis; calymmatobacterium (donovania) granulomatis: granuloma inguinale; chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.); doxycycline is indicated in the treatment of infections caused by the following gram-negative microorganisms: vibrio species: cholera; brucella species: brucellosis (in conjunction with streptomycin); yersinia pestis: plague; francisella tularensis: tularaemia; bartonella bacilliformis: bartonellosis; bacteroides species. doxycycline is active against both pre-erythrocytic and asexual bloodstages of plasmodium falciparum. the tetracyclines are only partially active against the pre-erythrocytic stages of plasmodium vivax, and protection depends on drug suppression of the blood stages. doxycycline has no activity against the relapsing forms (hypnozoites) of plasmodium vivax. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p.vivax. as there are relatively few locations where p.vivax does not co-exist to some extent with p.falciparum, it is recommended that doxycycline should be used routinely with other agents, eg. chloroquine. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum: syphilis; treponema pertenue: yaws; neisseria gonorrhoeae: gonorrhoea. doxycycline may be a useful adjunct to amoebicides in the treatment of acute intestinal amoebiasis. in the treatment of severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is not the drug of choice in the following: any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxylin should not be used for these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci, (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice.

DOXSIG doxycycline 100mg (as hydrochloride) tablet blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

doxsig doxycycline 100mg (as hydrochloride) tablet blister pack

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 115.4 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - infections caused by the following organisms; mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents). borreliae (relapsing fever). calymmatobacterium (donovania) granulomatis (granuloma inguinale). infection caused by the following gram-negative microorganisms: vibrio species (chlorea), brucella sp. (brucellosis; in conjunction with streptomycin), haemophilus ducreyi (chancroid), yersinia pestis (plague), francisella turarenis (tularaemia), bartonella bacilliformis (bartonellosis), bacteroides sp. when penicillin is contraindicated, doxy-100 is an alternative drug in the treatment of infections due to : treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). doxy-100 is not the drug of choice in the treatment of any type of staphylococcal infection or infections due to streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxy-100 should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis, doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example, chloroquine.

Ronaxan 100 mg tablets for dogs and cats אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

ronaxan 100 mg tablets for dogs and cats

boehringer ingelheim vetmedica gmbh - doxycycline hyclate - tablet - 100 mg/tablet - doxycycline

DOXYCYCLINE SANDOZ doxycycline 100mg (as monohydrate) tablet blister pack אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

doxycycline sandoz doxycycline 100mg (as monohydrate) tablet blister pack

sandoz pty ltd - doxycycline monohydrate, quantity: 104.1 mg (equivalent: doxycycline, qty 100 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate; hydrogenated castor oil; povidone; magnesium stearate - infections caused by the following micro-organisms: mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always elminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline, or in combination with topical agents.) borreliae (relapsing fever); calymmatobacterium (donovania) granulomatis (granuloma inguinale). doxycycline sandoz is indicated for the treatment of anthrax due to bacillus anthracis, including inhalational anthrax (post-exposure) to reduce the incidence or progression of disease following exposure to aerosolized bacillus anthracis (see dosage and administration). infections caused by the following gram-negative micro-organisms: vibrio sp. (cholera); brucella sp. (brucellosis; in conjunction with streptomycin); yersinia pestis (plague); francisella tularensis (tularaemia); bartonella bacilliformis (bartonellosis); bacteriodes sp. when penicillin is contraindicated, doxycycline is an alternative medicine in the treatment of infections due to: treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). note: doxycycline sandoz is not the medicine of choice in the treatment of any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxycycline sandoz should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual medicine of choice. in acute intestinal amoebiasis doxycycline sandoz may be a useful adjunct to amoebicides. in severe acne doxycycline may be a useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by plasmodium vivax. as there are relatively few locations where p. vivax does not coexist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example chloroquine.

TETRACYCLINE HYDROCHLORIDE capsule
TETRACYCLINE HYDROCHLORIDE- tetracycline hydrochloride capsule ארצות הברית - אנגלית - NLM (National Library of Medicine)

tetracycline hydrochloride capsule tetracycline hydrochloride- tetracycline hydrochloride capsule

avkare - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus

TETRACYCLINE HYDROCHLORIDE- tetracycline hydrochloride capsule ארצות הברית - אנגלית - NLM (National Library of Medicine)

tetracycline hydrochloride- tetracycline hydrochloride capsule

harris pharmaceutical, inc - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hcl capsules, usp and other antibacterial drugs, tetracycline hcl capsules, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline hcl capsules, usp is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline hcl capsules, usp should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory t